Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences

Psychedelic research has entered a renewed period of activity often described as a "third wave," dominated by clinician-led, medicalised studies in neuroscience and therapeutic settings. Shaw and colleagues note that, despite growing clinical evidence, comparatively little research examines non‑clinical use of psychedelics—particularly magic mushrooms—that occurs outside of supervised or research settings. Existing non‑clinical literature tends to emphasise harms, often relies on surveys or online forum analyses, and therefore may underrepresent users' nuanced experiences and the meanings they attach to use. This study set out to address that gap by exploring how young adults in Greater Victoria, Canada, use magic mushrooms, what lasting effects they perceive, and what strategies they employ to optimise trips. The investigators aimed to expand knowledge of non‑clinical substance use practices and to highlight perceived post‑trip impacts and harm‑minimisation or optimisation strategies reported by users themselves.

The study used qualitative, semi‑structured, one‑to‑one interviews with 20 emerging adults. Participants were purposively and conveniently sampled from the University of Victoria community between February and March 2018. Eligibility criteria required participants to be aged 19–24, to have lived in Victoria for at least six months, and to have used magic mushrooms within the prior three months; these restrictions were intended to focus on the emerging‑adult life stage and to reduce recall bias. Recruitment was achieved via campus posters and social media; participants received a $20 CAD honorarium and a referral card for counselling services. Study procedures were approved by the university ethics board and participants provided written informed consent. Interviews lasted 25–53 minutes (mean = 35 minutes) and covered topics such as frequency of use, access and availability, knowledge about mushrooms, initial trial of the drug, social accommodation and cultural acceptance. Interviews were audio recorded and transcribed verbatim. The analysis followed thematic analysis procedures: a semantic codebook was developed, coding was completed in NVivo (Version 11) using a deductive approach, and reflexive journaling was used to surface researcher assumptions. Two coding cycles were completed; themes were iteratively developed, compared against the full data set, and vetted by all authors to support trustworthiness. Participants were assigned pseudonyms to protect confidentiality.

Twenty participants (10 men, 10 women) took part; the mean age was 20.9 years and 95% were university students. Two major themes emerged: (1) post‑trip impacts, with sub‑themes of transformation and learning experiences; and (2) strategies to optimise the experience, with sub‑themes of doing research and relying on peer supports. Under the post‑trip impacts theme, many participants described lasting effects persisting for weeks, months or longer. Transformations were characterised as durable internal changes that participants generally evaluated as positive: examples included improved mood, greater emotional regulation, reassessment of values and priorities, and reductions in anxiety or depressive symptoms attributed to confronting difficult memories during trips. Several participants linked their mushroom experiences to substantial life changes; one commented, "It's changed me... I just feel like being a more happy person," and another recounted a trip that altered suicidal thinking by evoking concern for family and future. The learning experiences sub‑theme captured how participants framed challenging or difficult trips as opportunities for insight rather than as inherently harmful. Although participants acknowledged the potential for "bad trips," most reported that difficult moments could yield personal growth if navigated with patience and support. Illustrative remarks included a participant's observation that early trip anxiety could be worked through to reach a more constructive understanding of negative feelings. The optimisation theme described preparatory and in‑trip strategies. Many participants conducted research prior to and after use, consulting mainstream media, peer‑reviewed articles, online forums, harm‑reduction websites and experienced peers; some kept "trip journals" to record doses, thoughts and outcomes. A minority deliberately avoided government sources they judged unreliable. Peer support practices included using trusted companions, employing sober "trip sitters," informing friends of plans, and creating written safety prompts; women in the sample reported particular emphasis on written contingency plans such as a note with instructions and money for a taxi. Overall, participants framed these practices as methods to enhance both safety and the therapeutic or insight potential of their experiences.

Shaw and colleagues interpret the findings as indicating that, within this sample of emerging adults, magic mushroom use was commonly associated with perceived lasting positive impacts, including personal transformation and improved psychological well‑being. The investigators argue that challenging experiences often labelled as harmful in prior literature were frequently appraised by participants as opportunities for learning and growth rather than as direct harms. This reconceptualisation is presented alongside references to clinical work showing that intense acute anxiety during supervised psilocybin sessions can coexist with high rates of subsequent well‑being and positive behavioural change. The authors situate their results within broader observations that psychedelic use has been associated in some studies with increased coping skills, life satisfaction and lower prevalence of certain markers of psychological distress. They also highlight the central role of social and peer support in participants' practices, noting that community support has been linked with better outcomes in other plant‑medicine contexts. Participants' engagement in self‑directed research is discussed as a possible mechanism for informed, lower‑risk use; the authors observe a perceived lack of recreational‑use research and suggest that users are actively seeking information to understand risk and benefit. Key limitations acknowledged by the investigators include the narrow age range (19–24), which limits applicability to other age groups; the broad interview scope that reduced depth in some areas; the cross‑sectional design, which precludes causal inference; non‑probability sampling, which limits generalisability; and reliance on self‑report, which carries potential recall and social desirability biases (the three‑month use criterion was intended to mitigate recall bias, and the interviewer sought to reduce social desirability through non‑judgemental engagement). The authors conclude that further research on non‑clinical magic mushroom use could better inform strategies to maximise positive outcomes and minimise harms for users and wider society.